title: Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.
abstract: The development of Aβ-PET imaging agents has allowed for detection of fibrillar Aβ deposition in vivo and marks a major advancement in understanding the role of Aβ in Alzheimer's disease (AD). Imaging Aβ thus has many potential clinical benefits: early or perhaps preclinical detection of disease and accurately distinguishing AD from dementias of other non-Aβ causes in patients presenting with mild or atypical symptoms or confounding comorbidities (in which the distinction is difficult to make clinically). From a research perspective, imaging Aβ allows us to study relationships between amyloid pathology and changes in cognition, brain structure, and function across the continuum from normal aging to mild cognitive impairment (MCI) to AD; and to monitor the effectiveness of anti-Aβ drugs and relate them to neurodegeneration and clinical symptoms. Here, we will discuss the application of one of the most broadly studied and widely used Aβ imaging agents, Pittsburgh Compound-B (PiB).
authors: Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
authors: Ann D
authors: AD
authors: Cohen
authors: Gil D
authors: GD
authors: Rabinovici
authors: Chester A
authors: CA
authors: Mathis
authors: William J
authors: WJ
authors: Jagust
authors: William E
authors: WE
authors: Klunk
authors: Milos D
authors: MD
authors: Ikonomovic
mesh_terms: D000544:Alzheimer Disease / Q000000981:diagnostic imaging; D000682:Amyloid / Q000032:analysis* / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000032:analysis* / Q000378:metabolism*; D000814:Aniline Compounds / Q000737:chemistry / Q000493:pharmacokinetics; D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D006801:Humans; D057054:Molecular Imaging / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*; D013844:Thiazoles / Q000737:chemistry / Q000493:pharmacokinetics
chemical_list: C475519:2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; D000682:Amyloid; D016229:Amyloid beta-Peptides; D000814:Aniline Compounds; D001057:Apolipoproteins E; D013844:Thiazoles